Back to Market Feed

EMGALITY 120 MG/ML SYRINGE

galcanezumab-gnlm
$734.8510per ML

Strength

120 mg/mL

NDC

00002237711

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

GALCANEZUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761063

On Market Since

9/27/2018

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+2.8%

3Y

+12.0%

5Y

+20.9%

All

+31.2%

Generic Alternatives

1 alternative • Same active ingredient

EMGALITY 120 MG/ML PEN
Brand
00002143611•Eli Lilly and Company
$735.2057
+0% more

Related Drugs

Same classification

No related drugs found.